COMMENT from

Wearable technology offerings for cardiology expand with RhythMedix’s new RhythmStar cardiac monitor

On 18 February 2021, RhythMedix announced the launch of its newest-generation wearable cardiac monitor, the RhythmStar. This device boasts cellular connectivity and joins a roster of wearable cardiac devices already available on the market.


In healthcare, “wearable technologies” refers to non-invasive devices that capture, analyse, and aggregate physiological data to improve personal health and well-being. While historically utilised mainly for fitness tracking, the usage of wearable technology has been steadily growing in the healthcare field.


In the cardiology space, a common application for wearable technology is heart rhythm monitoring. Heart rhythm issues, or “arrhythmias,” may affect as many as 2% of adults.


As of 2021, GlobalData estimates that atrial fibrillation (a specific type of arrhythmia) affects nearly four million Americans. It is important to diagnose and treat heart arrhythmias early because, if left untreated, they can lead to heart failure or, in some cases, even sudden cardiac death.


There are a number of wearable devices that detect heart arrhythmias via electrocardiogram (ECG) monitoring. This capability has even been incorporated into more generic devices; for instance, Apple’s SmartWatch has been FDA-approved to take clinical-grade ECG recordings and detect atrial fibrillation.

On the other hand, some devices are manufactured specifically for this purpose, such as AliveCor’s Kardia device.


Typically, the ECG recordings from these devices are sent to a nearby cellular device such as a smart phone, where an application collects and reads the ECG recordings and, in some cases, transmits them to physicians wirelessly.


The RhythmStar cardiac monitor, a new wearable ECG monitoring device from RhythMedix, has built-in cellular connectivity. This means that the device itself can collect ECG recordings and send them wirelessly to physicians without the need for an intermediate device such as a phone.


This streamlined approach to wearable ECG monitoring may entice more people to use these types of devices, raising their market potential.


Overall, if more people are able to diagnose their heart arrhythmias earlier thanks to wearable devices, the pool of patients requiring treatment for their arrhythmias will increase. Subsequently, the market for devices to treat heart arrhythmias (such as electrophysiology ablation devices or pacemakers) will grow.

For more insight and data, visit GlobalData's Medical Intelligence Centre

06/22/2021 18:41:54
  • Home | A new frontier for robotic surgery
  • In this issue
  • Contents
  • BioInteractions Company Insight
  • BioInteractions
  • Formacoat Company Insight
  • Formacoat
  • Briefing
  • Industry news
  • Covid-19 executive briefing by GlobalData
  • The medical industry briefing
  • Pulse Technologies Company Insight
  • Pulse Technologies
  • Watlow Company Insight
  • Watlow
  • Accumold
  • Comment
  • Wearable technology for cardiology expands with RhythMedix
  • Insightin Health aims to use AI to reduce healthcare costs
  • The effect of skin pigmentation on pulse oximeter results
  • Tidepool Loop and the future of digital diabetes care
  • 3D printing of drugs can revolutionise personalised medicine and improve sustain
  • ElectroCraft
  • ProByLas
  • Smiths Interconnect
  • Sandvik Company Insight
  • Sandvik
  • In Depth
  • How can smaller medtech companies protect their IP?
  • Medical video games: Level Ex enters the pharma-sales relationship
  • Robotic gynaecology: a new frontier in surgery launches in London
  • WheezeScan: device sparks hope for detecting asthma attacks in under-fives
  • Medicine music: how an earbud could treat arthritis and migraines
  • Kar-go: could an autonomous robot be the new face of drug transport?
  • The game-changing potential of digital therapeutics with Dr Brennan Spiegel
  • Can AI predict depression?
  • HirLan Company Insight
  • HirLan
  • Photonic Company Insight
  • Photonic
  • Asahi Intecc
  • In Data
  • Deals analysis
  • The medical industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next Issue